COPD recent findings: Impact on clinical practice

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 7, Issue 3, 2010, Pages 204-213

  Couillard, Annabelle ^a   Muir, Jean François ^a   Veale, Daniel ^a  

^a Fédération Antadir ^*  (France)

Author keywords

Co morbidities; COPD; Survival; Systemic disease

Indexed keywords

AIRWAY OBSTRUCTION; ANEMIA; ANXIETY; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; DYSPNEA; ENDOCRINE DISEASE; EXERCISE; HEART DISEASE; HUMAN; LUNG CANCER; METABOLIC DISORDER; MUSCLE DISEASE; NUTRITIONAL DISORDER; OSTEOPOROSIS; PATIENT CARE; PERSONAL AUTONOMY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; QUALITY OF LIFE; REVIEW; BREATHING MECHANICS; COMPLICATION; DISEASE COURSE; MORBIDITY; MUSCULAR DISEASES; NUTRITION DISORDERS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SURVIVAL RATE; TRENDS;

DISEASE PROGRESSION; HUMANS; MORBIDITY; MUSCULAR DISEASES; NUTRITION DISORDERS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MECHANICS; SURVIVAL RATE;

EID: 77952856115     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2010.482115     Document Type: Review

References (96)

1. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and cost of COPD. Eur Respir J 2006; 27:188-207.
2. Agusti A, Soriano JB. COPD as a systemic disease. COPD 2008; 5:133-138.
3. Decramer M, Rennard S, Troosters T, Mapel DW, Giardino N, Mannino D, Wouters E, Sethi S, Cooper CB. COPD as a lung disease with systemic consequences, clinical impacts, mechanisms and potential for early intervention. COPD 2008; 5: 235-256.
4. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33:1165-1185.
5. Celli BR, Cote CG, Marin J, Casanova C, Montes de Oca M, Mendez R, Pinto-Plata V, Cabral H. The body mass-index, airflow obstruction, dyspnea and exercise capacity index in COPD. N Engl J Med 2004; 350:1005-1012.
6. Coronell C, Orozco-Levi M, Ḿendez R, Ramírez-Sarmiento A, Ǵ aldiz JB, Gea J. Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J 2004; 24:129-136.
7. Allaire J, Maltais F, Doyon JF, Noel M, Leblanc P, Carrier G, Simard C, Jobin J. Peripheralmuscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax 2004; 59:673-678.
8. Couillard A, Koechlin C, Cristol JP, Varray A, Prefaut Ch. Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients. Eur Respir J 2002; 20:1-7.
9. Van't hul A, Harllar J, Gosselink R, Hollander P, Postmus P, Kwakkel G. Quadricepsmuscle endurance in patients with chronic obstructive pulmonary disease. Muscle Nerve 2004; 29:267-274. (Pubitemid 38166850)
10. Gagnon P, Saey D, Vivodtzev I, Laviolette L, Mainguy V, Milot J, Provencher S, Maltais F. Impact of pre-induced quadriceps fatigue on exercise response in chronic obstructive pulmonary disease and healthy subjects. J Appl Physiol 2009 Jul 2. [Epub ahead of print).
11. Gosker H, Zeegers M, Wouters E, Schols A. Muscle fiber type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax 2007; 62:944-949.
12. Swallow E, Reyes D, Hopkinson N, Man W, Porcher R, Cetti E, Moore A, Moxham J, Polkey M. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007; 62:115-120.
13. Vilaro J, Rabinovich R, Gonzalez-deSuso JM, Troosters T, Rodríguez D, Barber̀a JA, Roca J. Clinical assessment of peripheral muscle function in patients with chronic obstructive pulmonary disease. Am J Phys Med Rehabil 2009; 88:39-46.
14. Man WD, Soliman MG, Nikoletou D, Harris ML, Rafferty GF, Mustfa N, Polkey MI, Moxham J. Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease. Thorax 2003; 58:665-669.
15. Couillard A, Prefaut C. From muscle disuse to myopathy in patients with COPD: potential contribution of oxidative stress. Eur Respir J 2005; 26:703-719.
16. Schols AMWJ, Soeters PB, Dingemans MC, Mostert R, Frantzen PJ, Wouters EFM. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147:1151-1156.
17. Creutzberg EC, Schols AM, Bothmer-Quaedvlieg FC, Wouters EF. Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function. Eur J Clin Nutr 1998; 52:396-401.
18. Schols AMWJ, Mostert R, Soeters PB, Saris WHM, Wouters EFM. Energy balance in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 143:1248-1252.
19. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, Sørensen TI, Lange P. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006; 173:79-83.
20. Ischaki E, Papatheodorou G, Gaki E, Papa I, Koulouris N, Loukides S. Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest 2007; 132:164-169.
21. Remels AH, Gosker HR, Van Der Velden J, Langen RC, Schols AM. Systemic inflammation and skeletal muscle dysfunction in chronic obstructive pulmonary disease: state of the art and novel insights in regulation of muscle plasticity. Clin Chest Med 2007; 28:537-552.
22. Cano NJ, Roth H, Court-Ortuńe I, Cynober L, Ǵerard- Boncompain M, Cuvelier A, Laaban JP, Melchior JC, Pichard C, Raphäel JC, Pison CM. Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation. Eur Respir J 2002; 20:30-37.
23. Creutzberg EC, Casaburi R. Endocrinological disturbances in chronic obstructive pulmonary disease. Eur Respir J Suppl 2003; 46:76s-80s.
24. Dimopoulou I, Ilias I, Mastorakos G, Mantzos E, Roussos C, Koutras DA. Effects of severity of chronic obstructive pulmonary disease on thyroid function. Metabolism 2001; 50:1397-1401.
25. Kamischke A, Kemper DE, Castel MA, Luthke M, Rolf C, Behre HM, et al. Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J 1998; 11:41-45.
26. Debigare R, Marquis K, Cote CH, Tremblay RR, Michaud A, Leblanc P, et al. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 2003; 124:83-89.
27. Scalvini S, Volterrani M, Vitacca M, Clark AL, Solfrini R, Panzali AM, Ferrari R, Levi GF. Plasma hormone levels and haemodynamics in patients with chronic obstructive lung disease. Monaldi Arch Chest Dis 1996; 51:380-386.
28. John M, Lange A, Hoernig S, Witt C, Anker SD. Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases. Int J Cardiol 2006; 111:365-370.
29. Cote C, Zilberberg MD, Mody SH, Dordelly LJ, Celli B. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 2007; 29:923-929.
30. Chambellan A, Chailleux E, Similowski T; ANTADIR Observatory Group. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 2005; 128:1201-1208.
31. John M, Hoernig S, Doehner W, Okonko DD, Witt C, Anker SD. Anemia and inflammation in COPD. Chest 2005; 127:825-829.
32. Schönhofer B, Wenzel M, Geibel M, Köhler D. Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease. Crit Care Med 1998; 26:1824-1828.
33. Graat-Verboom L, Wouters EF, Smeenk FW, Van Den Borne BE, Lunde R, SpruitMA. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J 2009; 34:209-218.
34. Jørgensen NR, Schwarz P. Osteoporosis in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 2008; 14:122-127.
35. Vrieze A, de Greef MH, Wijkstra PJ, Wempe JB. Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporos Int 2007; 18:1197-1202.
36. Janssens W, Lehouck A, Carremans C, Bouillon R, Mathieu C, Decramer M. Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med 2009; 179:630-636.
37. Graat-Verboom L, Spruit MA, Van Den Borne BE, Smeenk FW, Martens EJ, Lunde R, Wouters EF, CIRO Network. Correlates of osteoporosis in chronic obstructive pulmonary disease: An underestimated systemic component. Respir Med 2009; 103:1143-1151.
38. Ferguson GT, Calverley PM, Anderson JA, Jenkins CR, Jones PW, Willits LR, Yates JC, Vestbo J, Celli B. Prevalence and progression of osteoporosis in patients with COPD. Results from TORCH Chest 2009 Jul 6. [Epub ahead of print]
39. Putman-Casdorph H, McCrone S. Chronic obstructive pulmonary disease, anxiety, and depression: state of the science. Heart Lung 2009; 38:34-47.
40. Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, Hanania NA; ACCPWorkshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 2008; 134:43S-56S.
41. Hynninen KM, Breitve MH, Wiborg AB, Pallesen S, Nordhus IH. Psychological characteristics of patients with chronic obstructive pulmonary disease: a review. J Psychosom Res 2005; 59: 429-443.
42. Gudmundsson G, Gislason T, Janson C, Lindberg E, Suppli Ulrik C, Brøndum E, Nieminen MM, Aine T, Hallin R, Bakke P. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med 2006; 100:87-93.
43. McCathie HC, Spence SH, Tate RL. Adjustment to chronic obstructive pulmonary disease: the importance of psychological factors. Eur Respir J 2002; 19:47-53.
44. Hill K, Geist R,Goldstein RS, Lacasse Y. Anxiety and depression in end-stage COPD. Eur Respir J 2008; 31:667-677.
45. Norwood RJ. A review of etiologies of depression in COPD. Int J Chron Obstruct Pulmon Dis 2007; 2:485-491.
46. Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly patients with chronic obstructive pulmonary disease. Age Ageing 2006; 35:457-459.
47. Al-Shair K, Dockry R, Mallia-Milanes B, Kolsum U, Singh D, Vestbo J. Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med 2009 Jun 25 [Epub ahead of print].
48. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32:962-969.
49. Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003; 52:812-817.
50. Marquis K, Maltais F, Duguay V, Bezeau AM, LeBlanc P, Jobin J, Poirier P. The metabolic syndrome in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2005; 25:226-232. (Pubitemid 41153761)
51. Fabbri LM, Luppi F, Begh́e B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J 2008; 31:204-212.
52. Watz H,Waschki B, Kirsten A,Müller KC, Kretschmar G, Meyer T, Holz O, Magnussen H. The Metabolic syndrome in patients with chronic bronchitis and COPD: Frequency and associated consequences for systemic inflammation and physical inactivity. Chest 2009 Jun 19. [Epub ahead of print].
53. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005; 128:2640-2646.
54. Rutten FH, Cramer MJ, Lammers JW, Grobbee DE, Hoes AW. Heart failure and chronic obstructive pulmonary disease: An ignored combination? Eur J Heart Fail 2006; 8:706-711.
55. Thurnheer R, Muntwyler J, Stammberger U, Bloch KE, Zollinger A, Weder W, Russi EW. Coronary artery disease in patients undergoing lung volume reduction surgery for emphysema. Chest 1997; 112:122-1118
56. Marquis K, Maltais F, Poirier P. Cardiovascular manifestations in patients with COPD. Rev Mal Respir 2008; 25:663-673.
57. Kleiger RE, Senior RM. Longterm electrocardiographic monitoring of ambulatory patients with chronic airway obstruction. Chest 1974;65:483-487.
58. Weitzenblum E, Kessler R, Oswald M, Fraisse P. Medical treatment of pulmonary hypertension in chronic lung disease. Eur Respir J 1994; 7:148-152. (Pubitemid 24075139)
59. Burger CD. Pulmonary hypertension in COPD: a review and consideration of the role of arterial vasodilators. COPD 2009; 6:137-144.
60. Thabut G, Dauriat G, Stern JB, Logeart D, Ĺevy A, Marrash-Chahla R, Mal H. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005; 127:1531-1536.
61. Thun MJ, Henley SJ, Burns D, Jemal A, Shanks TG, Calle EE. Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst 2006; 98:691-699.
62. Mannino DM, Aguayo SM, Petty TL, Redd SC. Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med 2003; 163:1475-1480.
63. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996; 313:711-715.
64. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer. Am J Respir Crit Care Med 1990; 141:613-617.
65. Islam SS, Schottenfeld D. Declining FEV1 and chronic productive cough in cigarette smokers: a 25 year prospective study of lung cancer incidence in Tecumseh, Michigan. Cancer Epidemiol Biomarkers Prev 1994; 3:289-298.
66. Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 2007; 176:285-290.
67. Wasswa-Kintu S, Gan WQ, Man SF, Pare PD, Sin DD. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 2005; 60:570-575.
68. Formiga F, Lopez-Soto A, Masanes F, Chivite D, Sacanella E, Pujol R. Influence of acute exacerbation of chronic obstructive pulmonary disease or congestive heart failure on functional decline after hospitalization in nonagenarian patients. Eur J Intern Med 2005; 16:24-28.
69. Almagro P, Calbo E, Ochoa de Echaguen A, et al. Mortality after hospitalization for COPD. Chest 2002; 121:1441-1448.
70. Rozzini R, Sabatini T, Cassinadri A, Boffelli S, Ferri M, Barbisoni P, Frisoni GB, Trabucchi M. Relationship between functional loss before hospital admission and mortality in elderly persons with medical illness. J Gerontol A Biol Sci Med Sci 2005; 60: 1180-1183.
71. Minicuci N, Maggi S, Noale M, et al. Predicting mortality in older patients. The VELCA Study. Aging Clin Exp Res 2003; 15:328-335.
72. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003; 167:544-549.
73. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004; 23: 28-33.
74. Takigawa N, Tada A, Soda R, Date H, Yamashita M, Endo S, Takahashi S, Kawata N, Shibayama T, Hamada N, Sakagucchi M, Hirano A, Kimura G, Okada C, Takahashi K. Distance and oxygen desaturation in 6-min walk test predict prognosis in COPD patients. Respir Med 2007; 1001:561-567.
75. Casanova. C, Cote C, Marin JM, Pinto-Plata V, De Torres JP, Aguirre-Jaime A, Vassaux C, Celli BR. Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest 2008; 134: 746-752.
76. Panos RJ, Eschenbacher W. Exertional desaturation in patients with chronic obstructive pulmonary disease. COPD 2009; 6:478-487.
77. Pitta F, Troosters T, Spruit MA, Decramer M, Gosselink R. Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2005; 86: 1979-1985.
78. Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. Eur Respir J 2009; 33:262-272.
79. Pitta F, Troosters T, Spruit MA, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171:972-977.
80. Garcia-Aymerich J, Serra I, Ǵomez FP, Farrero E, Balcells E, Rodríguez DA, de Batlle J, Gimeno E, Donaire-Gonzalez D, Orozco-Levi M, Sauleda J, Gea J, Rodriguez-Roisin R, Roca J, Agustí AG, Ant́o JM. Physical activity and clinical and functional status in COPD. Chest 2009; 136:62-70.
81. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Ant́o JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006; 61:772-778.
82. Garcia-Aymerich J, Farrero E, F́elez MA, Izquierdo J, Marrades RM, Ant ́o JM; Estudi del Factors de Risc d'Aguditzaci ́o de la MPOC investigators. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58:100-105.
83. Marquis K, Debigaŕe R, Lacasse Y, Leblanc P, Jobin J, Carrier G, Maltais F. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with COPD. Am J Resp Crit Care Med 2002; 166:809-813.
84. Esteban C, Quintana JM, Aburto M, Moraza J, Egurrola M, España PP, Ṕerez-Izquierdo J, Capelastegui A. Predictors of mortality in patients with stable COPD. J J Gen Intern Med J 2008; 23:1829-1834.
85. Antonelli-Incalzi R, Pedone C, Scarlata S, Battaglia S, Scichilone N, Forestiere F, Bellia V. Correlates of mortality in elderly COPD patients: focus on health-related quality of life. Respirology 2009; 14:98-104.
86. Conte ME, Pedone C, Forastiere F, Bellia V, Antonelli-Incalzi R. Discriminative and predictive properties of disease-specific and generic health status indexes in elderly COPD patients. BMC Pulm Med 2008; 8:14.
87. Halpin DM, Peterson S, Larsson TP, Calverley PM. Identifying COPD patients at increased risk of mortality: predictive value of clinical study baseline data. Respir Med 2008; 102:1615-1624.
88. Domingo-Salvany A, Lamarca R, Ferrer M, Garcia-Aymerich J, Alonso J, F́elez M, Khalaf A, Marrades RM, Monśo E, Serra-Batlles J, Ant ́o JM. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166:680-685. (Pubitemid 34971850)
89. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999; 116:1632-1637.
90. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121:1434-1440.
91. Schembri S, Anderson W, Morant S, Winter J, Thompson P, Pettitt DM, Macdonald TH,Winter J. A predictive model of hospitalisation and death from chronic obstructive pulmonary disease. Respir Med 2009; Jun 8. [Epub ahead of print].
92. Tsimogianni AM, Papiris SA, Stathopoulos GT, Manali ED, Roussos C, Kotanidou A. Predictors of outcome after exacerbation of chronic obstructive pulmonary disease. J Gen Intern Med 2009; Jul 14. [Epub ahead of print].
93. Celli BR, Cote CG, Lareau SC, Meek PM. Predictors of survival in COPD: more than just the FEV1. Respir Med 2008; 102 Suppl 1:S27-S35.
94. Marin JM, Carrizo SJ, Casanova C, Martinez-Camblor P, Soriano JB, Agusti AG, Celli BR. Prediction of risk of COPD exacerbations by the BODE index. Respir Med 2009; 103:373-378.
95. Medinas Amoŕos M, Mas-Tous C, Renom-Sotorra F, Rubí-Ponseti M, Centeno-Flores MJ, Gorriz-Dolz MT. Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index. Chron Respir Dis 2009; 6:75-80.
96. Funk GC, Kirchheiner K, Burghuber OC, Hartl S. BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD-A cross-sectional study. Respir Res 2009; 10:1.